METiS, an AI Drug Firm, Plans $200 Million IPO in Hong Kong
METiS Pharmaceuticals, an AI-driven drug delivery and discovery firm based in Hangzhou, is exploring the possibility of launching an initial public offering (IPO) in Hong Kong.
IPO
OpenAI in Talks with Microsoft to Secure New Funding and Prepare for Future IPO
OpenAI, the company, has entered into intense negotiations with Microsoft to revise the terms of their multibillion-dollar partnership.
